Showing results (21-30 of 182) with videos related to
Sort By:
Pageof 19
Cancer|September 1, 2005
Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxaneMonica N Fornier, Shanu Modi, Katherine S Panageas, et al.Mutation Research|December 17, 2008
cDNA analysis demonstrates that the BRCA2 intronic variant IVS4-12del5 is a deleterious mutationLiying Zhang, Ruben Bacares, Sherry Boyar, et al.The Journal of Biological Chemistry|December 18, 2007
EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchangeKotha Subbaramaiah, Clifford Hudis, Sung-Hee Chang, et al.Clinical Breast Cancer|May 13, 2009
Phase I study of nonpegylated liposomal doxorubicin plus trastuzumab in patients with HER2-positive breast cancerMaria Theodoulou, Gerald Batist, Susana Campos, et al.Journal of the American Geriatrics Society|June 17, 2006
Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal studyArti Hurria, Carol Rosen, Clifford Hudis, et al.Clinical Breast Cancer|October 28, 2004
Effect of cardiac dysfunction on treatment outcomes in women receiving trastuzumab for HER2-overexpressing metastatic breast cancerDebu Tripathy, Andrew Seidman, Deborah Keefe, et al.Clinical Breast Cancer|September 1, 2010
Adjuvant taxanes: more to the storyDevika Gajria, Andrew Seidman, Chau DangBreast (Edinburgh, Scotland)|January 21, 2012
Epirubicin: is it like doxorubicin in breast cancer? A clinical reviewMustafa Khasraw, Richard Bell, Chau DangJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2014
Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancerChau Dang, Neil Iyengar, Farrah Datko, et al.Expert Opinion on Drug Safety|August 16, 2006
Cardiac dysfunction associated with trastuzumabKaren Lisa Smith, Chau Dang, Andrew D SeidmanPageof 19